Home

gebogen Hohe Belichtung Artikel pancreatic cancer overall survival Verdammt irgendwo Betrachtung

Home:Pancreatic cancer
Home:Pancreatic cancer

Prognostic factors in patients with pancreatic cancer
Prognostic factors in patients with pancreatic cancer

Further evidence of the prognostic role of pretreatment levels of CA 19-9  in advanced pancreatic cancer
Further evidence of the prognostic role of pretreatment levels of CA 19-9 in advanced pancreatic cancer

Stratified survival of resected and overall pancreatic cancer patients in  Europe and the USA in the early twenty-first century: a large,  international population-based study | BMC Medicine | Full Text
Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text

Development and validation of a prognostic model to predict the prognosis  of patients who underwent chemotherapy and resection of pancreatic  adenocarcinoma: a large international population-based cohort study | BMC  Medicine | Full
Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study | BMC Medicine | Full

Publication in the Cancers journal on the benefits of GemciTest®
Publication in the Cancers journal on the benefits of GemciTest®

Overall survival in 379 patients with pancreatic cancer was... | Download  Scientific Diagram
Overall survival in 379 patients with pancreatic cancer was... | Download Scientific Diagram

CA19-9 decrease at 8 weeks as a predictor of overall survival in a  randomized phase III trial (MPACT) of weekly nab-paclitaxel plus  gemcitabine versus gemcitabine alone in patients with metastatic pancreatic  cancer -
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer -

Overall survival of patients with metastatic pancreatic cancer... |  Download Scientific Diagram
Overall survival of patients with metastatic pancreatic cancer... | Download Scientific Diagram

Cancers | Free Full-Text | The Role of Location of Tumor in the Prognosis  of the Pancreatic Cancer | HTML
Cancers | Free Full-Text | The Role of Location of Tumor in the Prognosis of the Pancreatic Cancer | HTML

pancreas cancer
pancreas cancer

MR-Guided Radiotherapy Prolongs Median Survival for Inoperable, Locally  Advanced Pancreatic Cancer | Imaging Technology News
MR-Guided Radiotherapy Prolongs Median Survival for Inoperable, Locally Advanced Pancreatic Cancer | Imaging Technology News

Post-surgical overall survival of pancreatic cancer according to c-fos  expression in cancer tissues (Log-rank test; P = 0.020).
Post-surgical overall survival of pancreatic cancer according to c-fos expression in cancer tissues (Log-rank test; P = 0.020).

Clinical Predictors of Second-Line Chemotherapy Benefit in Patients with Pancreatic  Cancer | Insight Medical Publishing
Clinical Predictors of Second-Line Chemotherapy Benefit in Patients with Pancreatic Cancer | Insight Medical Publishing

Overall survival in patients with pancreatic cancer receiving matched  therapies following molecular profiling: a retrospective analysis of the  Know Your Tumor registry trial - The Lancet Oncology
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology

Survival of pancreatic cancer patients is negatively correlated with age at  diagnosis: a population-based retrospective study | Scientific Reports
Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports

Overall survival curves in patients with advanced pancreatic cancer... |  Download Scientific Diagram
Overall survival curves in patients with advanced pancreatic cancer... | Download Scientific Diagram

5 States Where Pancreatic Cancer Prevalence Is the Highest | The Motley Fool
5 States Where Pancreatic Cancer Prevalence Is the Highest | The Motley Fool

Survival of pancreatic cancer patients is negatively correlated with age at  diagnosis: a population-based retrospective study | Scientific Reports
Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports

Cancer Research and Treatment
Cancer Research and Treatment

Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve  Patients with Metastatic Pancreatic Cancer | Clinical Cancer Research
Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer | Clinical Cancer Research

Evaluation of the prognostic value of the new AJCC 8th edition staging  system for patients with pancreatic adenocarcinoma; a need to subclassify  stage III? - ScienceDirect
Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III? - ScienceDirect

Overall survival in patients with pancreatic cancer according to the... |  Download Scientific Diagram
Overall survival in patients with pancreatic cancer according to the... | Download Scientific Diagram

Prognostic Factors of Unresectable Pancreatic Cancer Treated with  Nafamostat Mesilate Combined with Gemcitabine Chemotherapy | Anticancer  Research
Prognostic Factors of Unresectable Pancreatic Cancer Treated with Nafamostat Mesilate Combined with Gemcitabine Chemotherapy | Anticancer Research

Prognosis of distal pancreatic cancers controlled by stage
Prognosis of distal pancreatic cancers controlled by stage

Survival Stats for Pancreas Cancer
Survival Stats for Pancreas Cancer

Proposal of predictive model on survival in unresectable pancreatic cancer  receiving systemic chemotherapy
Proposal of predictive model on survival in unresectable pancreatic cancer receiving systemic chemotherapy